Hims & Hers Health (HIMS) Intangibles (2020 - 2026)
Hims & Hers Health (HIMS) reported Intangibles of $261.0 million for Q1 2026, up 501.03% on a YoY basis from $43.4 million in Q1 2025, and up 33.1% sequentially from $196.1 million in Q4 2025.
Hims & Hers Health (HIMS) Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Intangibles data on file, last reported at $261.0 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 501.03% year-over-year to $261.0 million; the trailing twelve-month figure through Mar 2026 stood at $261.0 million (up 501.03% YoY), and the FY2025 full-year result was $196.1 million, up 351.78% from the prior year.
- Intangibles rose to $261.0 million in Q1 2026, from $196.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $261.0 million in Q1 2026 to a low of $17.1 million in Q2 2024.
- A 5-year average of $60.6 million and a median of $23.8 million in 2022 frame the typical range for Intangibles.
- Across the five-year window, Intangibles declined 17.98% in 2022 and soared 501.03% in 2026, its largest moves.
- Tracing HIMS's Intangibles over 5 years: stood at $21.8 million in 2022, then decreased by 14.96% to $18.6 million in 2023, then surged by 133.71% to $43.4 million in 2024, then soared by 351.78% to $196.1 million in 2025, then surged by 33.1% to $261.0 million in 2026.
- Business Quant data shows HIMS's Intangibles at $261.0 million in Q1 2026, $196.1 million in Q4 2025, and $194.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | 261.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261.03 Mn |
| Dec 31, 2025 | 196.12 Mn |
| Sep 30, 2025 | 194.93 Mn |
| Jun 30, 2025 | 40.66 Mn |
| Mar 31, 2025 | 43.43 Mn |
| Dec 31, 2024 | 43.41 Mn |
| Sep 30, 2024 | 44.82 Mn |
| Jun 30, 2024 | 17.13 Mn |
| Mar 31, 2024 | 17.86 Mn |
| Dec 31, 2023 | 18.57 Mn |
| Sep 30, 2023 | 19.30 Mn |
| Jun 30, 2023 | 19.96 Mn |
| Mar 31, 2023 | 20.91 Mn |
| Dec 31, 2022 | 21.84 Mn |
| Sep 30, 2022 | 22.09 Mn |
| Jun 30, 2022 | 23.81 Mn |
| Mar 31, 2022 | 24.85 Mn |
| Dec 31, 2021 | 25.89 Mn |
| Sep 30, 2021 | 26.93 Mn |
| Dec 31, 2020 | 59,000.00 |